Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment
- PMID: 26232199
- PMCID: PMC4661217
- DOI: 10.1007/s40273-015-0311-x
Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment
Abstract
Background: To judge whether an intervention offers value for money, the incremental costs per gained quality-adjusted life-year (QALY) need to be compared with some relevant threshold, which ideally reflects the monetary value of health gains. Literature suggests that this value may depend on the equity context in which health gains are produced, but the value of a QALY in relation to equity considerations has remained largely unexplored.
Objective: The objective of this study was to estimate the social marginal willingness to pay (MWTP) for QALY gains in different equity subgroups, using a discrete choice experiment (DCE). Both severity of illness (operationalized as proportional shortfall) and fair innings (operationalized as age) were considered as grounds for differentiating the value of health gains.
Methods: We obtained a sample of 1205 respondents, representative of the adult population of the Netherlands. The data was analysed using panel mixed multinomial logit (MMNL) and latent class models.
Results: The panel MMNL models showed counterintuitive results, with more severe health states reducing the probability of receiving treatment. The latent class models revealed distinct preference patterns in the data. MWTP per QALY was sensitive to severity of disease among a substantial proportion of the public, but not to the age of care recipients.
Conclusion: These findings emphasize the importance of accounting for preference heterogeneity among the public on value-laden issues such as prioritizing health care, both in research and decision making. This study emphasises the need to further explore the monetary value of a QALY in relation to equity considerations.
Figures
Similar articles
-
Inquiry into the relationship between equity weights and the value of the QALY.Value Health. 2012 Dec;15(8):1119-26. doi: 10.1016/j.jval.2012.07.002. Epub 2012 Sep 25. Value Health. 2012. PMID: 23244815
-
Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment.Med Decis Making. 2015 Jan;35(1):94-105. doi: 10.1177/0272989X14547915. Epub 2014 Aug 21. Med Decis Making. 2015. PMID: 25145575
-
Reconciliation of economic concerns and health policy: illustration of an equity adjustment procedure using proportional shortfall.Pharmacoeconomics. 2004;22(17):1097-107. doi: 10.2165/00019053-200422170-00001. Pharmacoeconomics. 2004. PMID: 15612829
-
Willingness to pay for a QALY: theoretical and methodological issues.Pharmacoeconomics. 2005;23(5):423-32. doi: 10.2165/00019053-200523050-00002. Pharmacoeconomics. 2005. PMID: 15896094 Review.
-
Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY.Health Policy. 2014 Jun;116(2-3):281-8. doi: 10.1016/j.healthpol.2014.02.009. Epub 2014 Feb 28. Health Policy. 2014. PMID: 24690334 Review.
Cited by
-
Using discrete choice model to elicit preference for health-care priority setting.J Educ Health Promot. 2019 Jun 27;8:117. doi: 10.4103/jehp.jehp_404_18. eCollection 2019. J Educ Health Promot. 2019. PMID: 31334269 Free PMC article.
-
Value judgment of new medical treatments: Societal and patient perspectives to inform priority setting in The Netherlands.PLoS One. 2020 Jul 9;15(7):e0235666. doi: 10.1371/journal.pone.0235666. eCollection 2020. PLoS One. 2020. PMID: 32645035 Free PMC article.
-
When is it too expensive? Cost-effectiveness thresholds and health care decision-making.Eur J Health Econ. 2019 Mar;20(2):175-180. doi: 10.1007/s10198-018-1000-4. Eur J Health Econ. 2019. PMID: 30187251 No abstract available.
-
Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review.Pharmacoeconomics. 2018 Feb;36(2):175-187. doi: 10.1007/s40273-017-0575-4. Pharmacoeconomics. 2018. PMID: 28975582
-
Systematic Review of the Relative Social Value of Child and Adult Health.Pharmacoeconomics. 2024 Feb;42(2):177-198. doi: 10.1007/s40273-023-01327-x. Epub 2023 Nov 9. Pharmacoeconomics. 2024. PMID: 37945778 Free PMC article.
References
-
- Claxton K, Walker S, Palmer S, Sculpher M. Appropriate perspectives for health care decisions. CHE research paper 54. York: Centre for Health Economics; 2010.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical